EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of Single‐Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma

Xincheng Yi iD, Zongming Jia iD, Jixiang Wu iD, Siyu Wang iD, Yiqi Yu iD, Ying Kong iD, Xuefeng He iD, Yuhua Huang iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/1916444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 08.04.2026. Verfasst von Xincheng Yi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China, sdfyy.cn. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Single-Cell Analysis, T-Lymphocyte Subsets, Kidney Neoplasms. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma (KIRC), the most prevalent pathological renal cell carcinoma (RCC) subtype, makes up approximately 75%–84% of total cases. KIRC is characterized by high heterogeneity, high metastasis rates, and a poor prognosis. Its incidence rate has continued to rise in recent years. We sought to construct new prognostic models to optimize treatment decisions, improve clinical benefits, and explore potential therapeutic targets.

Methods

This study integrated various omics data including single‐cell RNA seq (GSE171306), TCGA‐KIRC, GWAS, and validation datasets (GSE29609 and E‐MTAB‐1980). The scPagwas algorithm combines GWAS with scRNA‐seq to identify immune subgroups with high feature correlation. Key genes are identified through the combination of weighted correlation network analysis (WGCNA) with differentially expressed genes (DEGs). We built a clinical prognostic model by using machine learning algorithms and validated it through survival rate and receiver operating characteristic (ROC) analysis. We used cancer drug sensitivity genomics data to analyze drug sensitivity and performed molecular docking to identify potential therapeutic drugs.

Results

Using single‐cell RNA seq data, we identified T cell subsets as characteristic cell subsets in KIRC through scPagwas analysis. In single‐cell analysis, key genes in T cell subsets and genes with PCC values > 0.05 were combined with the core genes in DEGs and WGCNA modules, thus yielding 86 intersecting genes. These genes were significantly enriched in immune‐related pathways. We established a clinical prognostic model containing seven risk genes. Low‐risk patients exhibited substantial survival advantages. Time‐dependent ROC analysis indicated the prognostic model′s excellent clinical predictive value. Functional enrichment, immune infiltration, and somatic mutation analyses highlighted different biological mechanisms among risk populations. The SHAP values of the XGBoost and LightGBM machine learning algorithms indicated DOCK8 as a potential biomarker. Drug prediction and molecular docking predicted five potential drugs targeting DOCK8 (finasteride, nocodazole, palonosetron, pifithrin alpha, and topiramate).

Conclusion

Our systematic analysis of the immune microenvironment, key genes, and prognosis of KIRC highlighted the critical roles of T cell subsets. We additionally established an effective clinical prognostic model. Our findings provide new insights and potential targets for the precise diagnosis and targeted KIRC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellSingle-Cell AnalysisT-Lymphocyte SubsetsKidney NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticComputational BiologyBiomarkers, TumorAlgorithmsGene Expression ProfilingGenome-Wide Association StudySingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

DOCK8T cellclear cell renal cell carcinomascPagwassingle-cell data analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China, sdfyy.cn.
  • Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China, sysu.edu.cn.

ORCID-Profile: Xincheng Yi, Zongming Jia, Jixiang Wu, Siyu Wang, Yiqi Yu, Ying Kong, Xuefeng He, Yuhua Huang

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Yi, X., Jia, Z., Wu, J., Wang, S., Yu, Y., Kong, Y., He, X., & Huang, Y. (2026). Use of Single‐Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/1916444

Vancouver

Yi X, Jia Z, Wu J, Wang S, Yu Y, Kong Y, et al. Use of Single‐Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/1916444

BibTeX
@article{Yi2026,
  author = {Yi, Xincheng and Jia, Zongming and Wu, Jixiang and Wang, Siyu and Yu, Yiqi and Kong, Ying and He, Xuefeng and Huang, Yuhua},
  title = {Use of Single‐Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/1916444}
}
Kostenlos starten →